{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:34:17Z","timestamp":1775644457838,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4727,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/modpathol.2009.159","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T10:00:45Z","timestamp":1257501645000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":325,"title":["Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation"],"prefix":"10.1016","volume":"23","author":[{"given":"Leo A","family":"Niemeier","sequence":"first","affiliation":[]},{"given":"David J","family":"Dabbs","sequence":"additional","affiliation":[]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[]},{"given":"Joan M","family":"Striebel","sequence":"additional","affiliation":[]},{"given":"Rohit","family":"Bhargava","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.159_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/978-0-387-78818-0_13","article-title":"Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance","volume":"630","author":"Sengupta","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/modpathol.2009.159_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ncponc1179","article-title":"The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2","volume":"5","author":"Prat","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/modpathol.2009.159_bib3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/cncr.10854","article-title":"Trastuzumab-associated cardiotoxicity","volume":"95","author":"Keefe","year":"2002","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.159_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.159_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PPO.0b013e31818d839b","article-title":"Therapeutic strategies for triple-negative breast cancer","volume":"14","author":"Tan","year":"2008","journal-title":"Cancer J"},{"key":"10.1038\/modpathol.2009.159_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jso.20722","article-title":"Androgens and androgen receptors: a clinically neglected sector in breast cancer biology","volume":"95","author":"Moe","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1038\/modpathol.2009.159_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00268-007-0694-8","article-title":"A new hormonal therapy for estrogen receptor-negative breast cancer","volume":"31","author":"Hardin","year":"2007","journal-title":"World J Surg"},{"key":"10.1038\/modpathol.2009.159_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2217\/14796694.4.1.15","article-title":"Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory","volume":"4","author":"Nahleh","year":"2008","journal-title":"Future Oncol"},{"key":"10.1038\/modpathol.2009.159_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archsurg.139.1.50","article-title":"Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool","volume":"139","author":"Toth-Fejel","year":"2004","journal-title":"Arch Surg"},{"key":"10.1038\/modpathol.2009.159_bib10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/modpathol.2008.54","article-title":"Histopathologic variables predict Oncotype DX recurrence score","volume":"21","author":"Flanagan","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.159_bib11","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2009.159_bib12","first-page":"444","article-title":"Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers","volume":"2","author":"Bhargava","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/modpathol.2009.159_bib13","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.159_bib14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.159_bib15","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.159_bib16","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.159_bib17","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.159_bib18","unstructured":"Baehner FL, Watson D, Shak S, et al. Quantitative RT-PCR analysis of ER and PR by Oncotype DX indicates distinct and different associations with prognosis and prediction of tamoxifen benefit. 29th Annual San Antonio Breast Cancer Symposium 2006, Abstract # 45."},{"key":"10.1038\/modpathol.2009.159_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/PAP.0b013e3181832381","article-title":"Estrogen and Progesterone Receptors in Breast Carcinoma: Quantitation is Therapeutically Important","volume":"15","author":"Bhargava","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2009.159_bib20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.159_bib21","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/me.2007-0421","article-title":"Minireview: nuclear receptors and breast cancer","volume":"22","author":"Conzen","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1038\/modpathol.2009.159_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2407-8-149","article-title":"Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors","volume":"8","author":"Gonzalez","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2009.159_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1711700106","article-title":"Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors","volume":"170","author":"Isola","year":"1993","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.159_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.2910520415","article-title":"Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer","volume":"52","author":"Kuenen-Boumeester","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2009.159_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2478\/v10042-008-0039-y","article-title":"Androgen receptors as a prognostic and predictive factor in breast cancer","volume":"46","author":"Agrawal","year":"2008","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1038\/modpathol.2009.159_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncr.11532","article-title":"Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies","volume":"98","author":"Moinfar","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.159_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1038\/modpathol.2009.159_bib28","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.159_bib29","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1200\/JCO.2008.18.1024","article-title":"Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial","volume":"27","author":"Hugh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.159_bib30","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"Farmer","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.159_bib31","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1038\/sj.onc.1209415","article-title":"An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen","volume":"25","author":"Doane","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.159_bib32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.159_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0344-0338(97)80053-2","article-title":"Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ","volume":"193","author":"Gatalica","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1038\/modpathol.2009.159_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1524-4741.1996.tb00107.x","article-title":"Androgen receptor expression along with loss of bcl-2, ER, and PR expression in benign and malignant apocrine lesions of the breast: implications for therapy","volume":"2","author":"Tavassoli","year":"1996","journal-title":"Breast J"},{"key":"10.1038\/modpathol.2009.159_bib35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jcp.52.11.838","article-title":"Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors","volume":"52","author":"Selim","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2009.159_bib36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/modpathol.3800437","article-title":"Androgen receptors are frequently expressed in mammary and extramammary Paget's disease","volume":"18","author":"Liegl","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.159_bib37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1593\/neo.08274","article-title":"A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer","volume":"10","author":"Naderi","year":"2008","journal-title":"Neoplasia"},{"key":"10.1038\/modpathol.2009.159_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1309\/42F00D0DJD0J5EDT","article-title":"Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations","volume":"120","author":"Agoff","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.159_bib39","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1158\/1078-0432.CCR-08-1763","article-title":"Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer","volume":"15","author":"Gonzalez-Angulo","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.159_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.2005.02181.x","article-title":"Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast","volume":"47","author":"Honma","year":"2005","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2009.159_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10147-008-0770-6","article-title":"Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers","volume":"13","author":"Ogawa","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"10.1038\/modpathol.2009.159_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1507\/endocrj.K07E-053","article-title":"Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations","volume":"55","author":"Suzuki","year":"2008","journal-title":"Endocr J"},{"key":"10.1038\/modpathol.2009.159_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9610(03)00054-0","article-title":"The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression","volume":"185","author":"Calhoun","year":"2003","journal-title":"Am J Surg"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222027648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222027648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:02:29Z","timestamp":1760230949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222027648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0893395222027648"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.159","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}